Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|January 31, 2012
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)Helio S Sader, Susanne Paukner, Zrinka Ivezic-Schoenfeld, et al.
The Journal of Antimicrobial Chemotherapy|December 19, 2023
7-Year (2015-21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanismsSusanne Paukner, Rodrigo E Mendes, S J Ryan Arends, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 24, 2005
Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cellsPavol Kudela, Susanne Paukner, Ulrike Beate Mayr, et al.
Antibiotics (Basel, Switzerland)|December 24, 2021
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 TrialsSusanne Paukner, David Mariano, Anita F Das, et al.
Scientific Reports|December 14, 2016
A novel pleuromutilin antibacterial compound, its binding mode and selectivity mechanismZohar Eyal, Donna Matzov, Miri Krupkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 2015
Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureusZohar Eyal, Donna Matzov, Miri Krupkin, et al.
Cancer Letters|January 1, 2008
Effective gene transfer to melanoma cells using bacterial ghostsPavol Kudela, Susanne Paukner, Ulrike Beate Mayr, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2016
In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United StatesRodrigo E Mendes, David J Farrell, Robert K Flamm, et al.
Future Microbiology|March 14, 2022
A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteriaSusanne Paukner, Gregory J Moran, Christian Sandrock, et al.
International Journal of Molecular Sciences|May 25, 2024
In Vivo Immune-Modulatory Activity of Lefamulin in an Influenza Virus A (H1N1) Infection Model in MiceSusanne Paukner, Sandra Kimber, Charlotte Cumper, et al.
Pageof 4